⌕
Zai Lab · ZLAB · Nasdaq
Tenet 38 · Weak
Compare
$23.47−4.59%At closeTenet 38 · Weak
$23.47−1.13 (−4.59%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Zai Lab (ZLAB) Stock

Zai Lab (ZLAB) closed at $23.47 on Nov 16, 2026; its Tenet Score is 38 of 100 against 313 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

38 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$23.47
Nov 16, 2026
52-week range
15.96 – 29.02
low → high · as of close, Nov 13, 2026
Tenet Score
38/100
Weak · 313 Healthcare peers

Industry: Drugs

Zai Lab Limited scores 38/100. Weak. Quality is the soft spot versus 313 Healthcare peers. Insufficient inputs: Tenet 38 is built from 3 of 4 pillars, from 50% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=313
38/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
—
Quality
24
Health
38
Growth
53

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Value omitted — no data yet.
Value—QualityFHealthDGrowthCMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
—
Withheld: the figures this depends on are not on the same share, currency or period basis.
P/S
—
no P/S on file
ROE
−30%
return on equity
Operating margin
−49.9%
fiscal 2025, before interest and tax
Net margin
−44.9%
of revenue kept
Current ratio
2.04
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Market cap
—
no market cap on file
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Zai Lab Limited

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule pol…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=313) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 13 US ETFs · top wrappers by weightSee all ETFs holding ZLAB →

What sector and industry is Zai Lab in?

Zai Lab is in the Healthcare sector and the Drugs industry.

What is Zai Lab's Tenet Score?

Zai Lab's Tenet Score is 38 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.